Search

everythinglearnresearchcommunity

for

Search:↓

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Provenge extends prostate cancer survival by about 4 months.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

A new method accurately measures nine specific hormones in human blood.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Higher cholesterol levels increase aggressive prostate cancer risk.

Certain natural compounds called terpenes may help prevent prostate cancer.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.